Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.65
-0.2300-0.52%
Post-market: 43.830.1757+0.40%19:59 EDT
Volume:17.97M
Turnover:784.80M
Market Cap:63.26B
PE:17.69
High:43.97
Open:43.74
Low:43.30
Close:43.88
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.03
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.54
PE(LYR):22.50

Loading ...

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Sep 15

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Moderately bullish activity in Boston Scientific with shares up 4.76%

TIPRANKS
·
Sep 15

Movement Alert|Boston Scientific Rises 3.3% in Regular Trading, Sector-Wide Strength Lifts Medical Device Stocks Amid Post-Cyberattack Recovery

Market Focus
·
Sep 14

Bernstein Adjusts Price Target on Boston Scientific to $60 From $72, Keeps Outperform Rating

MT Newswires Live
·
Sep 14

Jefferies Sticks to Its Buy Rating for Boston Scientific (BSX)

TIPRANKS
·
Sep 11

Boston Scientific Corp. Stock Falls 4.1%, Underperforms Peers

Dow Jones
·
Sep 11

Movement Alert|Boston Scientific Falls 3.13% in Regular Trading, Cybersecurity Fallout Deepens as Citi Cuts Target Price Amid Margin Pressure

Market Focus
·
Sep 11

Boston Scientific Restores Key Operations After Cyberattack

Dow Jones
·
Sep 10

Boston Scientific Exec Says Co is Executing a Significant Restructuring Plan That Will Provide Some Financial Benefit

THOMSON REUTERS
·
Sep 10

Boston Scientific Exec Says Co is Facing Some Gross Margin Pressure Due to Watchman and Ep Trends

THOMSON REUTERS
·
Sep 10

Boston Scientific Exec Says Co Expects Minimal EPS Growth in 2027

THOMSON REUTERS
·
Sep 10

Boston Scientific Exec Says Co is Re-Evaluating 2027 Framework in Light of the Cyber Incident and Will Provide a Preview on October - Conf Call

THOMSON REUTERS
·
Sep 10

Boston Scientific Exec Says Formal 2027 Forecast Will be Given in January

THOMSON REUTERS
·
Sep 10

Boston Scientific price target lowered to $57 from $61 at Citi

TIPRANKS
·
Sep 10

Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating

MT Newswires Live
·
Sep 10

Boston Scientific’s RESPI Study Signals Progress in Wearable Breathing Monitoring

TIPRANKS
·
Sep 10

Hack Fallout Means Boston Scientific to Miss Financial Targets

Dow Jones
·
Sep 09

Boston Scientific is Maintained at Buy by BTIG

Dow Jones
·
Sep 09

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Dow Jones
·
Sep 09